() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Export

LGC Capital’s leading Australian medical cannabis LP partner, Little Green Pharma, commences commercial sales to patients, has its products accepted for major clinical trials, commences negotiations to export to Germany and announces plans for a new 500,000 square foot site

Oct. 5, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) ("LGC") is pleased to advise that Australian medical cannabis company Little Green Pharma (LGP) in which LGC has a 14.21% interest, has successfully completed harvest of its second commercial medical cannabis crop from its facility south of Perth in Western Australia.
Read more

WeedMD Exports Cannabis Genetics to Australia’s Medifarm

Sept. 13, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of cannabis, is pleased to announce it has completed the export of its cannabis genetics to Australia’s Medifarm, a privately-held Queensland-based licensed producer (“LP”) distinguished in Australia for being the first licensed medical cannabis producer to be authorized for therapeutic use. 
Read more

Tilray® Exports 2:100 CBD Oil to the United Kingdom

Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada, was successfully imported into the United Kingdom, to supply a pediatric patient in need.
Read more

Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares

The Offering will be conducted through a syndicate of agents on a best efforts basis led by Canaccord Genuity Corp., and including GMP Securities L.P., Sprott Private Wealth LP, and Cormark Securities Inc. (together, the "Agents").  The Company has also granted the Agents with an over-allotment option to offer and sell up to an additional 15% of the number of common shares sold in the Offering.
Read more